Biomerix, Inc.

 Company Summary:
  • Biomerix is a US based, privately-held biotechnology company commercializing proprietary non-resorbable and resorbable porous 3D synthetic polyurethane scaffolds for a variety of soft tissue repairs.
Transaction Overview:
  • On 1 July, 2014, Biomerix secured an investment and cardiovascular partnership with Edwards Lifesciences.
  • In conjunction, the Company entered into separate undisclosed partnerships for market applications in mesh, ophthalmology, and oncology.
Significance of the Transaction:
  • The strategic alliance permit the Company to build upon existing commercial development with industry leaders well positioned within specific surgical indications.
Healthios Role:
  • Healthios served as exclusive financial and strategic adviser to Biomerix.
  • This transaction highlights Healthios relationships with Strategics in a wide variety of sectors and multiple market processes to execute company objectives.